Free Newsletter
SPOTLIGHT: Quality control at Chinese heparin supplier
Curious how APP Pharmaceuticals' heparin supplier in China handles safety and quality control? Check out The Wall Street Journal's behind-the-scenes look at Shenzhen Hepalink Pharmaceutical. APP, remember, is supplying the lion's share of heparin in the U.S. in the wake of Baxter's big recall and production stoppage. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: